YBX1, Targeted By Microrna-382-5p, Promotes Laryngeal Squamous Cell Carcinoma Progression via Modulating RAS/MAPK Signaling
Article in Recent Patents on Anti-Cancer Drug Discovery (January 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Recent Patents on Anti-Cancer Drug Discovery (January 2024)
Article in Cancers (November 2023)
Article in Advanced Therapeutics (July 2023)